Skip to content

Ready to Sail: Evaluating Sailing's Feasibility as Ergotherapy

Pronti A Salpare: Studio di fattibilità Sull'Impatto Della Vela Come Ergoterapia in Pazienti Con Malattie Rare Scheletriche - Ready to Sail: Evaluating Sailing's Feasibility as Ergotherapy for Rare Skeletal Diseases

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06397443
Acronym
PaS
Enrollment
8
Registered
2024-05-02
Start date
2024-05-16
Completion date
2024-09-13
Last updated
2025-03-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Multiple Osteochondroma, Ollier Disease, Osteogenesis Imperfecta

Keywords

Rare Diseases, QoL, Movement confidence, Mental health, Social interaction, Sailing

Brief summary

Background Individuals with rare skeletal disorders frequently experience psychological distress, social isolation, unmet needs, and significant challenges due to limited treatment options. Adventure Therapy, employing exposure to natural environments, has shown promise in improving self-esteem, autonomy, and social skills in chronic illness and disability populations. This pilot study explores the feasibility and preliminary efficacy of a sailing-based intervention for enhancing physical, social, and psychological well-being in this specific population. Outcome Measures The primary outcome is to investigates the feasibility of sailing to improve well-being and quality of life in patients living with rare skeletal disorders. Furthermore, the investigators hypothesize that participation in a sailing program led by occupational therapists will lead to improvements in: * Movement confidence: assessing whether sailing enhances participants' ability to move and perform daily activities. * Mental health: evaluating if sailing reduces anxiety and fear and promotes self-esteem. * Social interaction: exploring if sailing fosters social connection and reduces feelings of isolation. Methods The study will use a prospective, single-arm, longitudinal design. Eight participants with rare skeletal disorders will be enrolled in a 5-day sailing-based occupational therapy intervention. Comprehensive pre- and post-intervention assessments will measure psychosocial factors, quality of life, functional mobility, kinesiophobia, and body segment movement using questionnaires and functional scales.

Detailed description

Rare skeletal diseases represent a significant global health burden, affecting millions of people worldwide. These chronic, debilitating conditions necessitate the development of optimized clinical pathways and comprehensive support systems. Adventure therapy (AT) has emerged as a promising intervention for individuals with chronic conditions, demonstrating improvements in self-esteem, autonomy, and social skills. Sailing, a form of AT, offers opportunities for physical activity, social inclusion, and emotional well-being in individuals with disabilities. This study aims to assess the feasibility of using sailing as an occupational therapy intervention for patients with rare skeletal diseases. We hypothesize that sailing can enhance physical, cognitive, and social functioning in this patient population. A pilot program of sailing lessons for patients with rare skeletal diseases will be conducted. Participants will undergo assessments of physical, cognitive, and social skills before and after the intervention. This study will be the first to explore the use of sailing-based AT for this patient population. The findings will inform the development of larger-scale studies and contribute to the optimization of rehabilitation programs for this patient population.

Interventions

OTHER5-day sailing activity

* Sailing activity (4 h/die) * Stretching exercises pre and post-sailing activity * Post-activity debriefing

Sponsors

Istituto Ortopedico Rizzoli
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Individuals of any gender * Diagnosis of a rare skeletal disease, confirmed clinically and/or molecularly * Age 12 years or older * No history of surgery within six months prior to study enrollment.

Exclusion criteria

* Individuals undergoing diagnostic evaluation for a rare skeletal disease * Participants younger than 12 years of age. * Individuals who underwent surgery within the preceding 6 months. * Participants with fractures or musculoskeletal injuries sustained within the past year. * Individuals who were unable to provide written informed consent.

Design outcomes

Primary

MeasureTime frameDescription
Health-related Quality of LifeT0: BaselineEuroQol 5-Dimension (EQ-5D) instrument offers valuable information about patient-reported health status. The questionnaire consists of two sections-descriptive system and visual analog scale (VAS)-and yields two scores: Index Value (IV), and overall health status (VAS). In the descriptive system section, patients report their level of problems in five dimensions-mobility, self-care, usual activities, pain/discomfort, and anxiety/depression-and rate their health on a 5-level options for adults, and 3-level for adolescents and children. Based on the pattern of their responses, patients generate a health profile ranging from best health (11111 = highest level) to worst health (55555 = lowest level). Each health profile is transformed into an IV, that varies from 0 (absence of life/death) to 1 (perfect health). The VAS measures the patients' overall health status, with a score ranging from 0 (The worst health you can imagine) to 100 (The best health you can imagine).

Secondary

MeasureTime frameDescription
BalanceT0: BaselineBerg Balance Scale is a 14-item objective measure that assesses static balance and fall risk, item-level scores range from 0-4, determined by ability to perform the assessed activity. The total score ranges from 0 to 56, with higher scores indicating better balance. A score of less than 45 suggests an increased risk of falling.
KinesiophobiaT0: BaselineThe Tampa Scale for Kinesiophobia (TSK) is a validated self-report questionnaire designed to assess the fear of movement or (re)injury in individuals experiencing pain or musculoskeletal disorders. The TSK consists of 13 items (Italian validated version), each rated on a 4-point Likert scale, ranging from 1 (Strongly Disagree) to 4 (Strongly Agree). The scores are summed to yield a total score ranging from 13 to 52, with higher scores indicating greater levels of kinesiophobia. The TSK includes two subscales: 1.Activity Avoidance, with a score ranging from 6 to 24; 2.Harm Beliefs, with a score ranging from 7 to 28. Higher scores on both the Activity Avoidance and Harm Beliefs subscales indicate greater levels of kinesiophobia, reflecting increased fear of movement due to injury concerns (Activity Avoidance subscale) or harmful beliefs about physical activity (Harm Beliefs subscale).
Well-being and Mental HealthT0: BaselineClinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) is a self-report questionnaire designed to assess psychological distress and monitor treatment response. It consists of 34 items evaluating emotional state and perceived well-being over the past week, rated on a 5-point Likert scale from 0 (Not at all) to 4 (Most or all of the time). The total score is calculated as the mean of all item scores and can be reported in two ways: 1.Raw score: The mean of all item scores (range: 0-4). 2.Standardized score: Obtained by multiplying the raw score by 10, yielding a scale from 0 to 40. The data presented in the results refer to the raw score. Score Interpretation: 0.00-0.99: No clinical distress or minimal risk. 1.00-1.99: Mild distress, potentially significant. 2.00-2.99: Moderate distress, generally indicative of the need for intervention. 3.00-4.00: Severe distress, highly indicative of the need for immediate clinical intervention.
Physical Functioning and Psychological Well-beingT0: BaselinePediatric Outcomes Data Collection (PODCI) evaluates functional health status through an 83-item questionnaire, and uses domain-specific scales. Each scale generates a score ranging from 0 to 100, with higher scores indicating better functioning or less impairment.
Self-esteemT0: BaselineRosenberg Self-Esteem Scale: 10-item scales, ranging from 0-30. Scores between 15 and 25 are within normal range; scores below 15 suggest low self-esteem.
Motor CoordinationT0: BaselinePerformance Oriented Mobility Assesment (Tinetti Balance Scale) is an administered 16-item task-oriented test that measures gait and balance abilities, primarily to assess fall risk. It uses a 3-point ordinal scale of 0, 1 and 2. Gait is scored over 12 and balance is scored over 16. The total score (Fall Risk) ranges from 0 to 28, with higher scores indicating better balance and gait performance (19 or below=High risk of falls; 20-23=Moderate risk of falls; 24-28=Low risk of falls).

Other

MeasureTime frameDescription
Well-being and Mental HealthT1Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) is a self-report measure of psychological distress designed to be administered during a course of treatment to determine treatment response. It compries 34 questions about how the participants have been feeling over the last week, using a 5-point Likert scale ranging from 0 (Not at all) to 4 (Most or all of the time). The total score is calculated as the mean of all item scores (ranging from 0 to 4) and can be reported either as a raw score or standardized (e.g., multiplying the mean by 10 to obtain a score on a 0-40 scale). Score Interpretation: 0-0.99: No clinical distress or minimal risk. 1.00-1.99: Mild distress, potentially significant. 2.00-2.99: Moderate distress, generally indicative of a need for intervention. 3.00-4.00: Severe distress, highly indicative of immediate clinical intervention.
Information on the Functioning and Disability of an IndividualT0Functional Independence Measure (FIM) is a validated clinician-administered tool designed to assess functional independence in individuals with neurological or musculoskeletal conditions. It evaluates the level of assistance required for daily activities across six domains: self-care, sphincter control, mobility, locomotion, communication, and social cognition. The FIM consists of 18 items, each rated on a 7-point ordinal scale (1 = total assistance, 7 = complete independence), with total scores ranging from 18 to 126. Higher scores indicate greater functional independence.
KinesiophobiaT1The Tampa Scale for Kinesiophobia (TSK) is a validated self-report questionnaire designed to assess the fear of movement or (re)injury in individuals experiencing pain or musculoskeletal disorders. The TSK consists of 13 items (Italian validated version), each rated on a 4-point Likert scale, ranging from 1 (Strongly Disagree) to 4 (Strongly Agree). The scores are summed to yield a total score ranging from 13 to 52, with higher scores indicating greater levels of kinesiophobia. The TSK includes two subscales: 1.Activity Avoidance, with a score ranging from 6 to 24; 2.Harm Beliefs, with a score ranging from 7 to 28. Higher scores on both the Activity Avoidance and Harm Beliefs subscales indicate greater levels of kinesiophobia, reflecting increased fear of movement due to injury concerns (Activity Avoidance subscale) or harmful beliefs about physical activity (Harm Beliefs subscale).

Countries

Italy

Participant flow

Recruitment details

The first participant was enrolled on May 16, 2024, and the last participant was also enrolled on May 16, 2024.

Pre-assignment details

Of 10 eligibility participants, 8 met inclusion criteria and were included in the study.

Participants by arm

ArmCount
Patients With Rare Skeletal Disorders
5-day sailing activity 5-day sailing activity: - Sailing activity (4 h/die) * Stretching exercises pre and post-sailing activity * Post-activity debriefing
8
Total8

Baseline characteristics

CharacteristicPatients With Rare Skeletal Disorders
Age, Continuous14 years
Race/Ethnicity, Customized
Caucasian
8 participants
Region of Enrollment
Italy
8 participants
Sex: Female, Male
Female
4 Participants
Sex: Female, Male
Male
4 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 8
other
Total, other adverse events
0 / 8
serious
Total, serious adverse events
0 / 8

Outcome results

Primary

Health-related Quality of Life

EuroQol 5-Dimension (EQ-5D) instrument offers valuable information about patient-reported health status. The questionnaire consists of two sections-descriptive system and visual analog scale (VAS)-and yields two scores: Index Value (IV), and overall health status (VAS). In the descriptive system section, patients report their level of problems in five dimensions-mobility, self-care, usual activities, pain/discomfort, and anxiety/depression-and rate their health on a 5-level options for adults, and 3-level for adolescents and children. Based on the pattern of their responses, patients generate a health profile ranging from best health (11111 = highest level) to worst health (55555 = lowest level). Each health profile is transformed into an IV, that varies from 0 (absence of life/death) to 1 (perfect health). The VAS measures the patients' overall health status, with a score ranging from 0 (The worst health you can imagine) to 100 (The best health you can imagine).

Time frame: T2: up to 3 weeks

ArmMeasureGroupValue (MEDIAN)
Patients With Rare Skeletal DisordersHealth-related Quality of LifeEQ-5D Index Value0.90 score on a scale
Patients With Rare Skeletal DisordersHealth-related Quality of LifeEQ-5D VAS93.50 score on a scale
Primary

Health-related Quality of Life

EuroQol 5-Dimension (EQ-5D) instrument offers valuable information about patient-reported health status. The questionnaire consists of two sections-descriptive system and visual analog scale (VAS)-and yields two scores: Index Value (IV), and overall health status (VAS). In the descriptive system section, patients report their level of problems in five dimensions-mobility, self-care, usual activities, pain/discomfort, and anxiety/depression-and rate their health on a 5-level options for adults, and 3-level for adolescents and children. Based on the pattern of their responses, patients generate a health profile ranging from best health (11111 = highest level) to worst health (55555 = lowest level). Each health profile is transformed into an IV, that varies from 0 (absence of life/death) to 1 (perfect health). The VAS measures the patients' overall health status, with a score ranging from 0 (The worst health you can imagine) to 100 (The best health you can imagine).

Time frame: T3: up to 3 months

ArmMeasureGroupValue (MEDIAN)
Patients With Rare Skeletal DisordersHealth-related Quality of LifeEQ-5D Index Value0.82 score on a scale
Patients With Rare Skeletal DisordersHealth-related Quality of LifeEQ-5D VAS83.50 score on a scale
Primary

Health-related Quality of Life

EuroQol 5-Dimension (EQ-5D) instrument offers valuable information about patient-reported health status. The questionnaire consists of two sections-descriptive system and visual analog scale (VAS)-and yields two scores: Index Value (IV), and overall health status (VAS). In the descriptive system section, patients report their level of problems in five dimensions-mobility, self-care, usual activities, pain/discomfort, and anxiety/depression-and rate their health on a 5-level options for adults, and 3-level for adolescents and children. Based on the pattern of their responses, patients generate a health profile ranging from best health (11111 = highest level) to worst health (55555 = lowest level). Each health profile is transformed into an IV, that varies from 0 (absence of life/death) to 1 (perfect health). The VAS measures the patients' overall health status, with a score ranging from 0 (The worst health you can imagine) to 100 (The best health you can imagine).

Time frame: T0: Baseline

ArmMeasureGroupValue (MEDIAN)
Patients With Rare Skeletal DisordersHealth-related Quality of LifeEQ-5D Index Value0.91 score on a scale
Patients With Rare Skeletal DisordersHealth-related Quality of LifeEQ-5D VAS84 score on a scale
Primary

Health-related Quality of Life

EuroQol 5-Dimension (EQ-5D) instrument offers valuable information about patient-reported health status. The questionnaire consists of two sections-descriptive system and visual analog scale (VAS)-and yields two scores: Index Value (IV), and overall health status (VAS). In the descriptive system section, patients report their level of problems in five dimensions-mobility, self-care, usual activities, pain/discomfort, and anxiety/depression-and rate their health on a 5-level options for adults, and 3-level for adolescents and children. Based on the pattern of their responses, patients generate a health profile ranging from best health (11111 = highest level) to worst health (55555 = lowest level). Each health profile is transformed into an IV, that varies from 0 (absence of life/death) to 1 (perfect health). The VAS measures the patients' overall health status, with a score ranging from 0 (The worst health you can imagine) to 100 (The best health you can imagine).

Time frame: T1: up to 2 weeks

ArmMeasureGroupValue (MEDIAN)
Patients With Rare Skeletal DisordersHealth-related Quality of LifeEQ-5D Index Value0.91 score on a scale
Patients With Rare Skeletal DisordersHealth-related Quality of LifeEQ-5D VAS90.50 score on a scale
Secondary

Balance

Berg Balance Scale is a 14-item objective measure that assesses static balance and fall risk, item-level scores range from 0-4, determined by ability to perform the assessed activity. The total score ranges from 0 to 56, with higher scores indicating better balance. A score of less than 45 suggests an increased risk of falling.

Time frame: T0: Baseline

ArmMeasureValue (MEDIAN)
Patients With Rare Skeletal DisordersBalance56 score on a scale
Secondary

Balance

Berg Balance Scale is a 14-item objective measure that assesses static balance and fall risk, item-level scores range from 0-4, determined by ability to perform the assessed activity. The total score ranges from 0 to 56, with higher scores indicating better balance. A score of less than 45 suggests an increased risk of falling.

Time frame: T1: up to 2 weeks

ArmMeasureValue (MEDIAN)
Patients With Rare Skeletal DisordersBalance56 score on a scale
Secondary

Balance

Berg Balance Scale is a 14-item objective measure that assesses static balance and fall risk, item-level scores range from 0-4, determined by ability to perform the assessed activity. The total score ranges from 0 to 56, with higher scores indicating better balance. A score of less than 45 suggests an increased risk of falling.

Time frame: T2: up to 3 weeks

ArmMeasureValue (MEDIAN)
Patients With Rare Skeletal DisordersBalance56 score on a scale
Secondary

Balance

Berg Balance Scale is a 14-item objective measure that assesses static balance and fall risk, item-level scores range from 0-4, determined by ability to perform the assessed activity. The total score ranges from 0 to 56, with higher scores indicating better balance. A score of less than 45 suggests an increased risk of falling.

Time frame: T3: up to 3 months

ArmMeasureValue (MEDIAN)
Patients With Rare Skeletal DisordersBalance56 score on a scale
Secondary

Kinesiophobia

The Tampa Scale for Kinesiophobia (TSK) is a validated self-report questionnaire designed to assess the fear of movement or (re)injury in individuals experiencing pain or musculoskeletal disorders. The TSK consists of 13 items (Italian validated version), each rated on a 4-point Likert scale, ranging from 1 (Strongly Disagree) to 4 (Strongly Agree). The scores are summed to yield a total score ranging from 13 to 52, with higher scores indicating greater levels of kinesiophobia. The TSK includes two subscales: 1.Activity Avoidance, with a score ranging from 6 to 24; 2.Harm Beliefs, with a score ranging from 7 to 28. Higher scores on both the Activity Avoidance and Harm Beliefs subscales indicate greater levels of kinesiophobia, reflecting increased fear of movement due to injury concerns (Activity Avoidance subscale) or harmful beliefs about physical activity (Harm Beliefs subscale).

Time frame: T0: Baseline

ArmMeasureGroupValue (MEDIAN)
Patients With Rare Skeletal DisordersKinesiophobiaActivity Avoidance Scale10 score on a scale
Patients With Rare Skeletal DisordersKinesiophobiaHarm Scale11 score on a scale
Patients With Rare Skeletal DisordersKinesiophobiaKinesiophobia21.50 score on a scale
Secondary

Kinesiophobia

The Tampa Scale for Kinesiophobia (TSK) is a validated self-report questionnaire designed to assess the fear of movement or (re)injury in individuals experiencing pain or musculoskeletal disorders. The TSK consists of 13 items (Italian validated version), each rated on a 4-point Likert scale, ranging from 1 (Strongly Disagree) to 4 (Strongly Agree). The scores are summed to yield a total score ranging from 13 to 52, with higher scores indicating greater levels of kinesiophobia. The TSK includes two subscales: 1.Activity Avoidance, with a score ranging from 6 to 24; 2.Harm Beliefs, with a score ranging from 7 to 28. Higher scores on both the Activity Avoidance and Harm Beliefs subscales indicate greater levels of kinesiophobia, reflecting increased fear of movement due to injury concerns (Activity Avoidance subscale) or harmful beliefs about physical activity (Harm Beliefs subscale).

Time frame: T3: up to 3 months

ArmMeasureGroupValue (MEDIAN)
Patients With Rare Skeletal DisordersKinesiophobiaActivity Avoidance Scale10.50 score on a scale
Patients With Rare Skeletal DisordersKinesiophobiaHarm Scale8 score on a scale
Patients With Rare Skeletal DisordersKinesiophobiaKinesiophobia18.50 score on a scale
Secondary

Kinesiophobia

The Tampa Scale for Kinesiophobia (TSK) is a validated self-report questionnaire designed to assess the fear of movement or (re)injury in individuals experiencing pain or musculoskeletal disorders. The TSK consists of 13 items (Italian validated version), each rated on a 4-point Likert scale, ranging from 1 (Strongly Disagree) to 4 (Strongly Agree). The scores are summed to yield a total score ranging from 13 to 52, with higher scores indicating greater levels of kinesiophobia. The TSK includes two subscales: 1.Activity Avoidance, with a score ranging from 6 to 24; 2.Harm Beliefs, with a score ranging from 7 to 28. Higher scores on both the Activity Avoidance and Harm Beliefs subscales indicate greater levels of kinesiophobia, reflecting increased fear of movement due to injury concerns (Activity Avoidance subscale) or harmful beliefs about physical activity (Harm Beliefs subscale).

Time frame: T2: up to 3 weeks

ArmMeasureGroupValue (MEDIAN)
Patients With Rare Skeletal DisordersKinesiophobiaActivity Avoidance Scale11 score on a scale
Patients With Rare Skeletal DisordersKinesiophobiaHarm Scale12 score on a scale
Patients With Rare Skeletal DisordersKinesiophobiaKinesiophobia22.50 score on a scale
Secondary

Motor Coordination

Performance Oriented Mobility Assesment (Tinetti Balance Scale) is an administered 16-item task-oriented test that measures gait and balance abilities, primarily to assess fall risk. It uses a 3-point ordinal scale of 0, 1 and 2. Gait is scored over 12 and balance is scored over 16. The total score (Fall Risk) ranges from 0 to 28, with higher scores indicating better balance and gait performance (19 or below=High risk of falls; 20-23=Moderate risk of falls; 24-28=Low risk of falls).

Time frame: T3: up to 3 months

ArmMeasureGroupValue (MEDIAN)
Patients With Rare Skeletal DisordersMotor CoordinationFall Risk28 score on a scale
Patients With Rare Skeletal DisordersMotor CoordinationGait12 score on a scale
Patients With Rare Skeletal DisordersMotor CoordinationBalance16 score on a scale
Secondary

Motor Coordination

Performance Oriented Mobility Assesment (Tinetti Balance Scale) is an administered 16-item task-oriented test that measures gait and balance abilities, primarily to assess fall risk. It uses a 3-point ordinal scale of 0, 1 and 2. Gait is scored over 12 and balance is scored over 16. The total score (Fall Risk) ranges from 0 to 28, with higher scores indicating better balance and gait performance (19 or below=High risk of falls; 20-23=Moderate risk of falls; 24-28=Low risk of falls).

Time frame: T0: Baseline

ArmMeasureGroupValue (MEDIAN)
Patients With Rare Skeletal DisordersMotor CoordinationBalance12 score on a scale
Patients With Rare Skeletal DisordersMotor CoordinationFall Risk28 score on a scale
Patients With Rare Skeletal DisordersMotor CoordinationGait16 score on a scale
Secondary

Motor Coordination

Performance Oriented Mobility Assesment (Tinetti Balance Scale) is an administered 16-item task-oriented test that measures gait and balance abilities, primarily to assess fall risk. It uses a 3-point ordinal scale of 0, 1 and 2. Gait is scored over 12 and balance is scored over 16. The total score (Fall Risk) ranges from 0 to 28, with higher scores indicating better balance and gait performance (19 or below=High risk of falls; 20-23=Moderate risk of falls; 24-28=Low risk of falls).

Time frame: T1: up to 2 weeks

ArmMeasureGroupValue (MEDIAN)
Patients With Rare Skeletal DisordersMotor CoordinationGait12 score on a scale
Patients With Rare Skeletal DisordersMotor CoordinationBalance16 score on a scale
Patients With Rare Skeletal DisordersMotor CoordinationFall Risk28 score on a scale
Secondary

Motor Coordination

Performance Oriented Mobility Assesment (Tinetti Balance Scale) is an administered 16-item task-oriented test that measures gait and balance abilities, primarily to assess fall risk. It uses a 3-point ordinal scale of 0, 1 and 2. Gait is scored over 12 and balance is scored over 16. The total score (Fall Risk) ranges from 0 to 28, with higher scores indicating better balance and gait performance (19 or below=High risk of falls; 20-23=Moderate risk of falls; 24-28=Low risk of falls).

Time frame: T2: up to 3 weeks

ArmMeasureGroupValue (MEDIAN)
Patients With Rare Skeletal DisordersMotor CoordinationGait12 score on a scale
Patients With Rare Skeletal DisordersMotor CoordinationBalance16 score on a scale
Patients With Rare Skeletal DisordersMotor CoordinationFall Risk28 score on a scale
Secondary

Physical Functioning and Psychological Well-being

Pediatric Outcomes Data Collection (PODCI) evaluates functional health status through an 83-item questionnaire, and uses domain-specific scales. Each scale generates a score ranging from 0 to 100, with higher scores indicating better functioning or less impairment.

Time frame: T3: up to 3 months

ArmMeasureGroupValue (MEDIAN)
Patients With Rare Skeletal DisordersPhysical Functioning and Psychological Well-beingHappiness Scale80 score on a scale
Patients With Rare Skeletal DisordersPhysical Functioning and Psychological Well-beingGlobal Functioning Scale85.73 score on a scale
Patients With Rare Skeletal DisordersPhysical Functioning and Psychological Well-beingUpper Extremity Scale97.92 score on a scale
Patients With Rare Skeletal DisordersPhysical Functioning and Psychological Well-beingTransfer & Basic Mobility Scale96.97 score on a scale
Patients With Rare Skeletal DisordersPhysical Functioning and Psychological Well-beingSports and Physical Functioning Scale88.19 score on a scale
Patients With Rare Skeletal DisordersPhysical Functioning and Psychological Well-beingPain/Comfort Scale67.22 score on a scale
Secondary

Physical Functioning and Psychological Well-being

Pediatric Outcomes Data Collection (PODCI) evaluates functional health status through an 83-item questionnaire, and uses domain-specific scales. Each scale generates a score ranging from 0 to 100, with higher scores indicating better functioning or less impairment.

Time frame: T2: up to 3 weeks

ArmMeasureGroupValue (MEDIAN)
Patients With Rare Skeletal DisordersPhysical Functioning and Psychological Well-beingUpper Extremity Scale97.92 score on a scale
Patients With Rare Skeletal DisordersPhysical Functioning and Psychological Well-beingTransfer & Basic Mobility Scale97.35 score on a scale
Patients With Rare Skeletal DisordersPhysical Functioning and Psychological Well-beingSports and Physical Functioning Scale81.94 score on a scale
Patients With Rare Skeletal DisordersPhysical Functioning and Psychological Well-beingPain/Comfort Scale83.61 score on a scale
Patients With Rare Skeletal DisordersPhysical Functioning and Psychological Well-beingHappiness Scale92.50 score on a scale
Patients With Rare Skeletal DisordersPhysical Functioning and Psychological Well-beingGlobal Functioning Scale86.40 score on a scale
Secondary

Physical Functioning and Psychological Well-being

Pediatric Outcomes Data Collection (PODCI) evaluates functional health status through an 83-item questionnaire, and uses domain-specific scales. Each scale generates a score ranging from 0 to 100, with higher scores indicating better functioning or less impairment.

Time frame: T1: up to 2 weeks

ArmMeasureGroupValue (MEDIAN)
Patients With Rare Skeletal DisordersPhysical Functioning and Psychological Well-beingUpper Extremity Scale97.92 score on a scale
Patients With Rare Skeletal DisordersPhysical Functioning and Psychological Well-beingTransfer & Basic Mobility Scale97.35 score on a scale
Patients With Rare Skeletal DisordersPhysical Functioning and Psychological Well-beingSports and Physical Functioning Scale81.53 score on a scale
Patients With Rare Skeletal DisordersPhysical Functioning and Psychological Well-beingPain/Comfort Scale71.39 score on a scale
Patients With Rare Skeletal DisordersPhysical Functioning and Psychological Well-beingHappiness Scale82.50 score on a scale
Patients With Rare Skeletal DisordersPhysical Functioning and Psychological Well-beingGlobal Functioning Scale86.71 score on a scale
Secondary

Physical Functioning and Psychological Well-being

Pediatric Outcomes Data Collection (PODCI) evaluates functional health status through an 83-item questionnaire, and uses domain-specific scales. Each scale generates a score ranging from 0 to 100, with higher scores indicating better functioning or less impairment.

Time frame: T0: Baseline

ArmMeasureGroupValue (MEDIAN)
Patients With Rare Skeletal DisordersPhysical Functioning and Psychological Well-beingUpper Extremity Scale95.83 score on a scale
Patients With Rare Skeletal DisordersPhysical Functioning and Psychological Well-beingTransfer & Basic Mobility Scale92.80 score on a scale
Patients With Rare Skeletal DisordersPhysical Functioning and Psychological Well-beingSports and Physical Functioning Scale73.96 score on a scale
Patients With Rare Skeletal DisordersPhysical Functioning and Psychological Well-beingPain/Comfort Scale81.11 score on a scale
Patients With Rare Skeletal DisordersPhysical Functioning and Psychological Well-beingHappiness Scale85 score on a scale
Patients With Rare Skeletal DisordersPhysical Functioning and Psychological Well-beingGlobal Functioning Scale84.68 score on a scale
Secondary

Self-esteem

Rosenberg Self-Esteem Scale is a 10-item scale that assesses the self-esteem, ranging from 0-30. Scores between 15 and 25 are within normal range; scores below 15 suggest low self-esteem.

Time frame: T3: up to 3 months

ArmMeasureValue (MEDIAN)
Patients With Rare Skeletal DisordersSelf-esteem21 score on a scale
Secondary

Self-esteem

Rosenberg Self-Esteem Scale: 10-item scales, ranging from 0-30. Scores between 15 and 25 are within normal range; scores below 15 suggest low self-esteem.

Time frame: T2: up to 3 weeks

ArmMeasureValue (MEDIAN)
Patients With Rare Skeletal DisordersSelf-esteem22 score on a scale
Secondary

Self-esteem

Rosenberg Self-Esteem Scale: 10-item scales, ranging from 0-30. Scores between 15 and 25 are within normal range; scores below 15 suggest low self-esteem.

Time frame: T1: up to 2 weeks

ArmMeasureValue (MEDIAN)
Patients With Rare Skeletal DisordersSelf-esteem21 score on a scale
Secondary

Self-esteem

Rosenberg Self-Esteem Scale: 10-item scales, ranging from 0-30. Scores between 15 and 25 are within normal range; scores below 15 suggest low self-esteem.

Time frame: T0: Baseline

ArmMeasureValue (MEDIAN)
Patients With Rare Skeletal DisordersSelf-esteem22 score on a scale
Secondary

Well-being and Mental Health

Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) is a self-report questionnaire designed to assess psychological distress and monitor treatment response. It consists of 34 items evaluating emotional state and perceived well-being over the past week, rated on a 5-point Likert scale from 0 (Not at all) to 4 (Most or all of the time). The total score is calculated as the mean of all item scores and can be reported in two ways: 1.Raw score: The mean of all item scores (range: 0-4). 2.Standardized score: Obtained by multiplying the raw score by 10, yielding a scale from 0 to 40. The data presented in the results refer to the raw score. Score Interpretation: 0.00-0.99: No clinical distress or minimal risk. 1.00-1.99: Mild distress, potentially significant. 2.00-2.99: Moderate distress, generally indicative of the need for intervention. 3.00-4.00: Severe distress, highly indicative of the need for immediate clinical intervention.

Time frame: T3: up to 3 months

ArmMeasureValue (MEDIAN)
Patients With Rare Skeletal DisordersWell-being and Mental Health1.25 units on a scale
Secondary

Well-being and Mental Health

Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) is a self-report questionnaire designed to assess psychological distress and monitor treatment response. It consists of 34 items evaluating emotional state and perceived well-being over the past week, rated on a 5-point Likert scale from 0 (Not at all) to 4 (Most or all of the time). The total score is calculated as the mean of all item scores and can be reported in two ways: 1.Raw score: The mean of all item scores (range: 0-4). 2.Standardized score: Obtained by multiplying the raw score by 10, yielding a scale from 0 to 40. The data presented in the results refer to the raw score. Score Interpretation: 0.00-0.99: No clinical distress or minimal risk. 1.00-1.99: Mild distress, potentially significant. 2.00-2.99: Moderate distress, generally indicative of the need for intervention. 3.00-4.00: Severe distress, highly indicative of the need for immediate clinical intervention.

Time frame: T2: up to 3 weeks

ArmMeasureValue (MEDIAN)
Patients With Rare Skeletal DisordersWell-being and Mental Health0.45 units on a scale
Secondary

Well-being and Mental Health

Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) is a self-report questionnaire designed to assess psychological distress and monitor treatment response. It consists of 34 items evaluating emotional state and perceived well-being over the past week, rated on a 5-point Likert scale from 0 (Not at all) to 4 (Most or all of the time). The total score is calculated as the mean of all item scores and can be reported in two ways: 1.Raw score: The mean of all item scores (range: 0-4). 2.Standardized score: Obtained by multiplying the raw score by 10, yielding a scale from 0 to 40. The data presented in the results refer to the raw score. Score Interpretation: 0.00-0.99: No clinical distress or minimal risk. 1.00-1.99: Mild distress, potentially significant. 2.00-2.99: Moderate distress, generally indicative of the need for intervention. 3.00-4.00: Severe distress, highly indicative of the need for immediate clinical intervention.

Time frame: T0: Baseline

ArmMeasureValue (MEDIAN)
Patients With Rare Skeletal DisordersWell-being and Mental Health0.85 units on a scale
Other Pre-specified

Information on the Functioning and Disability of an Individual

Functional Independence Measure (FIM) is a validated clinician-administered tool designed to assess functional independence in individuals with neurological or musculoskeletal conditions. It evaluates the level of assistance required for daily activities across six domains: self-care, sphincter control, mobility, locomotion, communication, and social cognition. The FIM consists of 18 items, each rated on a 7-point ordinal scale (1 = total assistance, 7 = complete independence), with total scores ranging from 18 to 126. Higher scores indicate greater functional independence.

Time frame: T0

Other Pre-specified

Information on the Functioning and Disability of an Individual

Functional Independence Measure (FIM) is a validated clinician-administered tool designed to assess functional independence in individuals with neurological or musculoskeletal conditions. It evaluates the level of assistance required for daily activities across six domains: self-care, sphincter control, mobility, locomotion, communication, and social cognition. The FIM consists of 18 items, each rated on a 7-point ordinal scale (1 = total assistance, 7 = complete independence), with total scores ranging from 18 to 126. Higher scores indicate greater functional independence.

Time frame: T3

Other Pre-specified

Kinesiophobia

The Tampa Scale for Kinesiophobia (TSK) is a validated self-report questionnaire designed to assess the fear of movement or (re)injury in individuals experiencing pain or musculoskeletal disorders. The TSK consists of 13 items (Italian validated version), each rated on a 4-point Likert scale, ranging from 1 (Strongly Disagree) to 4 (Strongly Agree). The scores are summed to yield a total score ranging from 13 to 52, with higher scores indicating greater levels of kinesiophobia. The TSK includes two subscales: 1.Activity Avoidance, with a score ranging from 6 to 24; 2.Harm Beliefs, with a score ranging from 7 to 28. Higher scores on both the Activity Avoidance and Harm Beliefs subscales indicate greater levels of kinesiophobia, reflecting increased fear of movement due to injury concerns (Activity Avoidance subscale) or harmful beliefs about physical activity (Harm Beliefs subscale).

Time frame: T1

Other Pre-specified

Well-being and Mental Health

Clinical Outcomes in Routine Evaluation-Outcome Measure (CORE-OM) is a self-report measure of psychological distress designed to be administered during a course of treatment to determine treatment response. It compries 34 questions about how the participants have been feeling over the last week, using a 5-point Likert scale ranging from 0 (Not at all) to 4 (Most or all of the time). The total score is calculated as the mean of all item scores (ranging from 0 to 4) and can be reported either as a raw score or standardized (e.g., multiplying the mean by 10 to obtain a score on a 0-40 scale). Score Interpretation: 0-0.99: No clinical distress or minimal risk. 1.00-1.99: Mild distress, potentially significant. 2.00-2.99: Moderate distress, generally indicative of a need for intervention. 3.00-4.00: Severe distress, highly indicative of immediate clinical intervention.

Time frame: T1

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026